Clinical Trials Browser

ibrutinib × Genitourinary × 1 year × Clear all

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT02899078 2025-05-18

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer

Phase 1/2 Completed

31 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell

Clinical Trials

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer